Novo Will Limit Wegovy’s China Launch to Avoid Global Disruption

Novo Nordisk A/S will restrict initial sales of its blockbuster obesity treatment Wegovy in China, as the drugmaker grapples with how to control access to the medicine for the world’s biggest population of obese people.



Source link
lol